Condition: Triple Negative Breast Cancer (TNBC), Early Setting · Sponsor: Universitaire Ziekenhuizen KU Leuven
LESLIE is a multicentric randomized controlled trial in patients with triple negative breast cancer receiving neoadjuvant chemo/immunotherapy (NAT). This trial investigates the hypothesis that adding a cyclic fasting-mimicking diet combined with exercise during the NAT improves the NAT's therapeutic efficacy, treatment tolerability and compliance, as well as improve quality of life.
This description comes directly from the study's public registry record.
Christine Desmedt, PhD · +3216321194 · christine.desmedt@kuleuven.be
Josephine Van Cauwenbenberge, MD · +3216321194 · josephine.vancauwenberge@kuleuven.be
Always discuss trial participation with your own doctor first.
| UZ Antwerpen | Antwerp, Belgium | Recruiting |
| Ziekenhuis aan de Stroom | Antwerp, Belgium | Not Yet Recruiting |
| Cliniques universitaires Saint-Luc (UCLouvain) | Brussels, Belgium | Recruiting |
| UZ Brussel | Brussels, Belgium | Recruiting |
| UZ Gent | Ghent, Belgium | Not Yet Recruiting |
| Jessa Ziekenhuis Hasselt | Hasselt, Belgium | Recruiting |
| AZ Groeninge | Kortrijk, Belgium | Recruiting |
| University Hospital Leuven | Leuven, Belgium | Recruiting |
| Centre Hospitalier Universitaire (CHU) UCL Liège | Liège, Belgium | Recruiting |
| Centre Hospitalier Universitaire (CHU) UCL Namur | Namur, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06831955